Evidence map›Paper›PMID 34626410›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2022

Role of HSPGs in Systemic Bacterial Infections.

Rafael S Aquino, Kazutaka Hayashida, Atsuko Hayashida, Pyong Woo Park

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pathogens that infect mammalian cells via sulfonated glycosaminoglycans.Frontiers in cellular and infection microbiology · 2025
    Review
  5. Sulfoglycodendron Antivirals with Scalable Architectures and Activities.Journal of chemical information and modeling · 2024
    Article
  6. Sulfoglycodendron Antivirals with Scalable Architectures and Activities.bioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rafael S AquinoDivision of Respiratory Diseases, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Kazutaka HayashidaDivision of Respiratory Diseases, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Atsuko HayashidaDivision of Respiratory Diseases, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Pyong Woo ParkDivision of Respiratory Diseases, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. pyong.park@childrens.harvard.edu.
Harvard University · USBoston Children's Hospital · US

Funding

Syndecan Regulation of Sepsis Host DefenseR01HL142213 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI PARK, PYONG WOO · 2018 to 2021
$2.0M
Proteoglycan-Chemokine Interactions in Lung DiseaseR01HL132573 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI PARK, PYONG WOO · 2017 to 2020
$1.9M
NHLBI NIH HHS R01 HL132573NHLBI NIH HHS R01 HL142213
6 · The paper itself

Abstract

Heparan sulfate proteoglycans (HSPGs) are at the forefront of host-microbe interactions. Cell surface HSPGs are thought to promote infection as attachment and internalization receptors for many bacterial pathogens and as soluble inhibitors of host immunity when released from the cell surface by ectodomain shedding. However, the importance of HSPG-pathogen interactions in vivo has yet to be clearly established. Here we describe several representative methods to study the role of HSPGs in systemic bacterial infections, such as bacteremia and sepsis. The overall experimental strategy is to use mouse models to establish the physiological significance of HSPGs, to determine the identity of HSPGs that specifically promote infection, and to define key structural features of HSPGs that enhance bacterial virulence in systemic infections.

Indexed as

Bacterial InfectionsAnimalsCell MembraneDisease Models, AnimalHeparan SulfateHeparan Sulfate ProteoglycansMiceSepsisHeparan SulfateHeparan Sulfate ProteoglycansBacteremiaHeparan sulfateHeparinHost defenseProteoglycanSepsisSyndecans

Identifiers

PMID34626410
PMCPMC8560348
OpenAlexW3203643876

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.